Abstract
Various E-ring hydroxylated antofine and cryptopleurine analogues were designed, synthesized, and tested against five human cancer cell lines. Interesting structure-activity relationship (SAR) correlations were found among these new compounds. The most potent compound 13b was further tested against a series of nonsmall cell lung cancer (NSCLC) cell lines in which it showed impressive antiproliferative activity. Mechanistic studies revealed that 13b is able to down-regulate HSP90 and β-catenin in A549 lung adenocarcinoma cells in a dose-dependent manner, suggesting a potential use for treating hedgehog pathway-driven tumorigenesis.
Original language | English |
---|---|
Pages (from-to) | 6751-6761 |
Number of pages | 11 |
Journal | Journal of Medicinal Chemistry |
Volume | 55 |
Issue number | 15 |
DOIs | |
Publication status | Published - Aug 9 2012 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery